PharmTech sat down with Joseph Principe, chief commercial officer at Abzena ahead of DCAT Week 2025 to get his perspective on how the geopolitical climate is impacting the industry.
Pharmaceutical Technology® spoke with Joseph Principe, chief commercial officer at Abzena about how current events around the world are impacting the bio/pharmaceutical industry, especially the supply chain and drug shortages.
According to Principe, the current geopolitical climate is creating uncertainty in the bio/pharmaceutical industry. “The industry doesn't really like uncertainty. I think the circumstances around [the] BIOSECURE [Act] or potential tariffs, all sort of create this uncertainty,” he says. “I think that is creating some tailwinds for Western suppliers, particularly those in the [United States]. But again, lots of uncertainty. I think we see that depending on the type of customer that we're talking to, some of the early developers have a little bit less concern about the geopolitical situation, and people who have supply chains embedded in the regions and in many cases, they're looking for alternatives to avoid some of the uncertainty.”
Abzena will be attending DCAT Week 2025, which is happening in New York City from March 17–20, 2025.
Click on the video above to watch the full interview.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.